| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 12/02/2004 | WO2004104180A2 Genes encoding carotenoid biosynthetic enzymes |
| 12/02/2004 | WO2004104178A2 Efficient haploid cell sorting for flow cytometer systems |
| 12/02/2004 | WO2004104171A2 Ranbp2 as modifier of the pten/igf pathway and methods of use |
| 12/02/2004 | WO2004104159A1 Method and apparatus for mechanical stimulation of tissue in vitro |
| 12/02/2004 | WO2004103427A1 Filling material and manipulation method |
| 12/02/2004 | WO2004103293A2 Modulators of the p2y10 receptor useful in altering t lymphocyte function |
| 12/02/2004 | WO2004103271A2 Disease prevention and vaccination prior to thymic reactivations |
| 12/02/2004 | WO2004103067A2 A transgenic animal model for cancer and stem cells |
| 12/02/2004 | WO2004090095A3 Generation of human regulatory t cells by bacterial toxins for the treatment of inflammatory disorders |
| 12/02/2004 | WO2004083364A3 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof |
| 12/02/2004 | WO2004081174A3 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 12/02/2004 | WO2004078909A8 Identification of antigen epitopes |
| 12/02/2004 | WO2004074497A3 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 12/02/2004 | WO2004072251A3 Directed genetic modifications of human stem cells |
| 12/02/2004 | WO2004014212A3 Self-assembled muscle-powered microdevices |
| 12/02/2004 | WO2004013308A3 Maxs as modifiers of the axin pathway and methods of use |
| 12/02/2004 | WO2004007665A3 Methods for inducing differentiation of embryonic stem cells and uses thereof |
| 12/02/2004 | WO2003089592A3 Enhancement of hematopoietic stem cell survival |
| 12/02/2004 | WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof |
| 12/02/2004 | WO2003084478A3 Antisense modulation of hmgi-c expression |
| 12/02/2004 | WO2003064665A3 Viral vector |
| 12/02/2004 | WO2003063767A3 Rsv proteins, antibodies, compositions, methods and uses |
| 12/02/2004 | WO2003056020A8 Expression vectors and promoters for heterologous gene expression |
| 12/02/2004 | WO2003050235A3 Polynucleotide encoding a novel human potassium channel alpha-subunit, k+alpham2 |
| 12/02/2004 | WO2003027240A3 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor |
| 12/02/2004 | WO2002068583A3 Enzymes having dehalogenase activity and methods of use thereof |
| 12/02/2004 | US20040244080 Wheat plants having increased resistance to imidazolinone herbicides |
| 12/02/2004 | US20040244070 Expression of polypeptides in rod outer segment membranes |
| 12/02/2004 | US20040243235 Regeneration torn ligaments; biocompatibility material with slits; seeding with fibroblast forming cells |
| 12/02/2004 | US20040242859 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 12/02/2004 | US20040242844 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 12/02/2004 | US20040242843 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/02/2004 | US20040242520 Expression of immonogenic substances |
| 12/02/2004 | US20040242517 A nucleic acid construct encoding the antigenic determinant of a mutable pathogen; an isolated cell containing the construct; genetic engineering; vaccination; immunotherapy |
| 12/02/2004 | US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis |
| 12/02/2004 | US20040242514 Xenogenic oligo or/and polyribonucleotides as agents for the treatment of malignant tumours |
| 12/02/2004 | US20040242513 Tub antisense constructs |
| 12/02/2004 | US20040242512 Novel vectors for animal cells and utilization thereof |
| 12/02/2004 | US20040242495 Methods and compositions for cryopreservation of dissociated primary animal cells |
| 12/02/2004 | US20040242487 Identifying a subject in need of inhibiting appetite or weight gain and administering an effective amount of an antagonist of melanocyte concentrating hormone (MCH) to subject, wherein antagonist binds an MCH receptor |
| 12/02/2004 | US20040242481 Use of hmgb1 for the activation of dendritic cells |
| 12/02/2004 | US20040242472 Use of artemin, a member of the gdnf ligand family |
| 12/02/2004 | US20040242469 Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof |
| 12/02/2004 | US20040242417 Medium for the production of an embryogenic callus from a plant sample and a medium for the regeneration of a plant sample |
| 12/02/2004 | US20040241856 Using hematopoietic stem cell inhibition polypeptide to control differentiation of progenitor cells; for use in tissue engineering, bone marrow transplantation and tumor therapeutics |
| 12/02/2004 | US20040241854 Mammalian cells comprising rna sequences directed towards gene which codes transcript for swedish double amyloid precursor protein mutation or a transcript for tau gene product for use in posttranscriptional gene silencing and treatment of alzheimer's disease; gene therapy |
| 12/02/2004 | US20040241852 Functional nucleotide sequence fragments which contain restriction enzyme recognition sites for use as insertional points of heterologous gene sequences |
| 12/02/2004 | US20040241849 Nutrient broth for in propagation, transformation and expression of exogenous gene in bacteria |
| 12/02/2004 | US20040241848 Method of detecting microorgan ISMS using labelled electron acceptors |
| 12/02/2004 | US20040241847 Transformed root nodule bacteria comprising genes coding for vibrio catalase for use in transforming plant roots and enhancing nitrogen fixation; pollution control and fertilizers |
| 12/02/2004 | US20040241846 Animal extarct; separation from insects; lignin degradation |
| 12/02/2004 | US20040241842 Stimulation of thymus for vaccination development |
| 12/02/2004 | US20040241841 Incubating dendritic precursor cells such as monocytes and plasmacytoid dendritic cells with immunostimulatory oligonucleotide to generate antigen presenting cells for use in treatment of cell proliferative disorders; immunotherapy |
| 12/02/2004 | US20040241840 Compositions for therapy |
| 12/02/2004 | US20040241839 Nutrient broth comprising lysophosphatidic acid receptor containing neuronal cells, nestin and tubulin for use in propagating neurons, oligodendrocytes and astrocytes; tissue engineering and organ development; remodeling nervous system tissue |
| 12/02/2004 | US20040241838 Reprograming/dedifferentiating somatic cell nucleus via propagation in nutrient broth comprising nuclear factors and soluble components of cytoplasm; tissue engineering and transplantation; generating mammalian pluripotent stem cells from somatic tissue; remodeling somatic nuclei; organ development model |
| 12/02/2004 | US20040241837 Methods for forming normal regenerated tissues, the normal regenerated tissues, and method of calibrating sensitivity and so on |
| 12/02/2004 | US20040241818 Assay |
| 12/02/2004 | US20040241807 Interleukin-1 related gene and protein |
| 12/02/2004 | US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241795 Compounds and methods for inhibiting axillary malodour |
| 12/02/2004 | US20040241792 Substrates and assays for beta-secretase |
| 12/02/2004 | US20040241791 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 12/02/2004 | US20040241761 Using human estrogen receptor gene expression as diagnostic indicator of diabetes; antidiabetic agents |
| 12/02/2004 | US20040241755 Human cell assay to determine effect of sample compounds on Col2 enhancer expression |
| 12/02/2004 | US20040241710 Methods of detecting colorectal cancer |
| 12/02/2004 | US20040241708 Plasmid for use as gene transfer tool in heterologous gene expression; bioreactors |
| 12/02/2004 | US20040241695 Hemocyanin nucleic acids and polypeptides and related vectors fusion protein conjugates cells and methods of use |
| 12/02/2004 | US20040241674 Plant synthesizing copolyesters from monomer derived from short-chain fatty acid and process for producing polyesters |
| 12/02/2004 | US20040241673 Non-cytotoxic pap mutants |
| 12/02/2004 | US20040241672 Library of a collection of cells |
| 12/02/2004 | US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines |
| 12/02/2004 | US20040241664 Protein Hydrolysates Enriched In Peptides Having A Carboxy Terminal Proline Residue |
| 12/02/2004 | US20040241640 Internalisation of virus into cells |
| 12/02/2004 | US20040241639 Human tachykinin-related splice variants and compositions thereof |
| 12/02/2004 | US20040241182 lymphocytes; immunogens; fusion proteins; for treatment/prevention of infection |
| 12/02/2004 | US20040241180 Notch |
| 12/02/2004 | US20040241176 Method of producing membrane vesicles |
| 12/02/2004 | US20040241171 Leukocyte inactivation module |
| 12/02/2004 | US20040241170 Fetal Antigen-1 (FA1/dlk1) gene expression/inhibition; populations enriched in dopaminergic neurons, neural progenitor cells or neural stem cells, for ex-vivo gene therapy; drug screening/design |
| 12/02/2004 | US20040241167 CD4/CD25 antigen containing cell, interleukin, CD8/CD28 antigen containing cell, and vitamin D3; for generating tolerogenic antigen-presenting cell; kits; for treatment of autoimmune diseases such as AIDS, cancer, and Hepatitis C-related disorders |
| 12/02/2004 | US20040241162 Activation and expansion of cells |
| 12/02/2004 | US20040241156 Gene expression inhibition; solid phase synthesis; drug screening; for treating cancer, central nervous system disorders, and chronic obstructive pulmonary disorder |
| 12/02/2004 | US20040241153 Methods of generating human cd4+ th1 cells |
| 12/02/2004 | US20040241148 skin components having three dimensional structure of the tissue from which they are derived, and having dimensions so as to allow diffusion of nutrients, gases and wastes to and from cells |
| 12/02/2004 | US20040241147 antigen presenting cells which express major histocomatibility complexes, used as vaccines |
| 12/02/2004 | US20040241145 adhesion of mesenchymal stem cells or osteoblasts to fibers and/or porometric material which can serve as biological scaffold for the cells; tissue engineering |
| 12/02/2004 | US20040241144 mixing of synovial fluid and mesenchymal cells for use in tissue engineering; prophylaxis of degenerative joint diseases |
| 12/02/2004 | US20040241140 Expression vectors able to elicit improved immune response and methods of using same |
| 12/02/2004 | CA2566749A1 Efficient haploid cell sorting for flow cytometer systems |
| 12/02/2004 | CA2528521A1 Disease prevention and vaccination prior to thymic reactivations |
| 12/02/2004 | CA2526661A1 Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein |
| 12/02/2004 | CA2526403A1 New enterovirus, vaccines, medicaments and diagnostic kits |
| 12/02/2004 | CA2526397A1 Preparation of endodermal stem cells |
| 12/02/2004 | CA2526275A1 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compostitions comprising them |
| 12/02/2004 | CA2525954A1 Ura5 gene and methods for stable genetic integration in yeast |
| 12/02/2004 | CA2525840A1 Ovr115 antibody composition and methods of use |
| 12/02/2004 | CA2525698A1 A nucleic acid construct containing a nucleic acid derived from the genome of hepatitis c virus (hcv) of genotype 2a, and a cell having such nucleic acid construct introduced therein |
| 12/02/2004 | CA2525519A1 Generation and isolation of antigen-specific t cells |